These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 2632645)
21. [Effect of Daflon 500 mg on reperfusion damage following ischemia and reperfusion of striated muscle]. Pickelmann S; Nolte D; Schütze E; Messmer K Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):353-6. PubMed ID: 14518274 [TBL] [Abstract][Full Text] [Related]
22. Activity of Daflon 500 mg on the hemorheological disorders in diabetes. Lacombe C; Lelievre JC; Bucherer C; Grimaldi A Int Angiol; 1989; 8(4 Suppl):45-8. PubMed ID: 2632648 [TBL] [Abstract][Full Text] [Related]
23. [Effect of daflon on the transcapillary fluid exchange in hindlimbs of anesthesized Wistar rats]. Murashov AN; Buriukov RI; Khokhlova ON; Medvedev OS Eksp Klin Farmakol; 2001; 64(2):67-8. PubMed ID: 11548453 [TBL] [Abstract][Full Text] [Related]
24. Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg. Tsouderos Y Int Angiol; 1989; 8(4 Suppl):53-9. PubMed ID: 2698902 [TBL] [Abstract][Full Text] [Related]
25. Assessment of vasoconstrictive potential of D-lysergic acid using an isolated bovine lateral saphenous vein bioassay. Klotz JL; Bush LP; Smith DL; Shafer WD; Smith LL; Vevoda AC; Craig AM; Arrington BC; Strickland JR J Anim Sci; 2006 Nov; 84(11):3167-75. PubMed ID: 17032812 [TBL] [Abstract][Full Text] [Related]
26. Spontaneous contractility of human placental vessels in vitro axipetal and isometric recording. Gonzalez Panizza VH; Benedetti WL; Alvarez H Reproduccion; 1980; 4(4):335-9. PubMed ID: 7215696 [TBL] [Abstract][Full Text] [Related]
27. Action of S 5682 on the complement system. In vitro and in vivo study. Di Perri T; Auteri A Int Angiol; 1988; 7(2 Suppl):11-5. PubMed ID: 3183451 [TBL] [Abstract][Full Text] [Related]
29. Hemorheological improvement after Daflon 500 mg treatment in diabetes. Lacombe C; Bucherer C; Lelievre JC Int Angiol; 1988; 7(2 Suppl):21-4. PubMed ID: 3183453 [TBL] [Abstract][Full Text] [Related]
30. [Ionic mechanisms of the electrical activity of the smooth-muscle cells of the lymphatic vessels]. Orlov RS; Lobov GI Fiziol Zh SSSR Im I M Sechenova; 1984 May; 70(5):712-21. PubMed ID: 6468701 [TBL] [Abstract][Full Text] [Related]
31. [Therapeutic effectiveness of flavonoids illustrated by daflon 500 mg]. Hitzenberger G Wien Med Wochenschr; 1997; 147(18):409-12. PubMed ID: 9454438 [TBL] [Abstract][Full Text] [Related]
32. Suppression of lymphatic vessel contractility with inhibitors of arachidonic acid metabolism. Johnston MG; Feuer C J Pharmacol Exp Ther; 1983 Aug; 226(2):603-7. PubMed ID: 6410049 [TBL] [Abstract][Full Text] [Related]
33. Mechanisms in experimental venous valve failure and their modification by Daflon 500 mg. Pascarella L; Lulic D; Penn AH; Alsaigh T; Lee J; Shin H; Kapur V; Bergan JJ; Schmid-Schönbein GW Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):102-10. PubMed ID: 17890112 [TBL] [Abstract][Full Text] [Related]
35. Effects of selected combinations of tall fescue alkaloids on the vasoconstrictive capacity of fescue-naive bovine lateral saphenous veins. Klotz JL; Kirch BH; Aiken GE; Bush LP; Strickland JR J Anim Sci; 2008 Apr; 86(4):1021-8. PubMed ID: 18192563 [TBL] [Abstract][Full Text] [Related]
36. Effect of diosmin upon red blood cell deformability and osmotic fragility. Relationship with lipid content. Garnier M; Perret G; Pilardeau P; Vaysse J; Rolland Y; Uzzan B; Vassy R Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):259-62. PubMed ID: 3386333 [TBL] [Abstract][Full Text] [Related]
37. [Diosmin in the treatment of venous disease: pharmacokinetics and pharmacodynamics (in Russian only)]. Talibov OB Khirurgiia (Mosk); 2019; (3):135-140. PubMed ID: 30938369 [TBL] [Abstract][Full Text] [Related]
38. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination. Tanaka T; Makita H; Ohnishi M; Mori H; Satoh K; Hara A; Sumida T; Fukutani K; Tanaka T; Ogawa H Cancer Res; 1997 Jan; 57(2):246-52. PubMed ID: 9000563 [TBL] [Abstract][Full Text] [Related]
39. A neuromodulatory role for neuronal nitric oxide in the rabbit renal artery. Vials AJ; Crowe R; Burnstock G Br J Pharmacol; 1997 May; 121(2):213-20. PubMed ID: 9154330 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of the clinical pharmacological activity of a phlebotonic agent. Application to the study of Daflon 500 mg. Duchene Marullaz P; Amiel M; Barbe R Int Angiol; 1988; 7(2 Suppl):25-32. PubMed ID: 3053940 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]